Table I.
Symbol | Description | Fold Change |
---|---|---|
Type 1 IFN response genes | ||
Ligands and their receptors | ||
Ifna2 | IFN-α2 | 12.4 |
Ifna4 | IFN-α4 | 18.3 |
Ifnar1 | IFN (α and β) receptor 1 | 10.0 |
Ifnar2 | IFN (α and β) receptor 2 | 31.8 |
Ifnb1 | IFN-β1, fibroblast | 19.3 |
Signaling molecules | ||
stat1 | Signal transducer and activator of transcription 1 | 8.1 |
stat2 | Signal transducer and activator of transcription 2 | 11.0 |
IFN-responsive genes | ||
Adar | Adenosine deaminase, RNA-specific | 7.7 |
Anxa11 | Annexin A11 | 8.6 |
Casp1 | Caspase 1 | 9.8 |
Cxcl10 | Chemokine (CXC motif) ligand 10 | 15.5 |
Eif2ak2 | Eukaryotic translation initiation factor 2α kinase 2 | 9.9 |
Ifi204 | IFN-activated gene 204 | 8.4 |
Ifit1 | IFN-induced protein with tetratricopeptide repeats 1 | 2.5 |
Isg15 | ISG15 ubiquitin-like modifier | 12.6 |
Isg20 | IFN-stimulated protein | 14.6 |
Mx1 | Myxovirus (influenza virus) resistance 1 | 4.5 |
MyD88 | Myeloid differentiation primary response gene 88 | 7.3 |
Nmi | N-myc (and stat) interactor | 2.6 |
Oas1a | 2′-5′ oligoadenylate synthetase 1A | 13.6 |
Tap1 | Transporter 1, ATP-binding cassette, subfamily B (MDR/TAP) |
13.4 |
Tnfsf10 | TNF (ligand) superfamily, member 10 | 26.2 |
Genes associated with intrinsic IFN resistance | ||
Signal transduction | ||
Prkcz | Protein kinase C, ζ | −2.2 |
Apoptosis | ||
Dad1 | Defender against cell death 1 | −2.2 |
Diablo | Diablo homolog (Drosophila) | 9.7 |
Transcription regulation | ||
Atf5 | Activating transcription factor 5 | 2.1 |
Irf2 | IFN regulatory factor 2 | 3.1 |
Irf3 | IFN regulatory factor 3 | −3.1 |
Pttg1 | Pituitary tumor-transforming gene 1 | 5.5 |
Cell growth | ||
Cd70 | CD70 Ag | 59.3 |
Cdkn1b | Cyclin-dependent kinase inhibitor 1B | −7.5 |
Hoxb2 | Homeo box B2 | 2.0 |
Ifi204 | IFN-activated gene 204 | 8.4 |
Vegfa | Vascular endothelial growth factor A | 170.8 |
Others | ||
Bst2 | Bone marrow stromal cell Ag 2 | −5.2 |
Cnp | 2′,3′-cyclic nucleotide 3′ phosphodiesterase | −3.5 |
H2-D1 | Histocompatibility 2, D region locus 1 | −3.8 |
H2-K1 | Histocompatibility 2, K1, K region | −2.3 |
H2-M10.1 | Histocompatibility 2, M region locus 10.1 | 3.7 |
Nrg1 | Neuregulin 1 | −4.2 |
The array was repeated three times to validate the findings.
−, Downregulation.